Ohcanbohtosat - Arlene A. Forastiere
- Čájehuvvo 1 - 20 / 43
- Sirdás čuovvovaš siidui
-
1
-
2
-
3
Organ Preservation for Advanced Larynx Cancer: Issues and Outcomes Dahkki Arlene A. Forastiere, Randal S. Weber, Andy Trotti
Almmustuhtton 2015Revisão -
4
HPV-associated head and neck cancer: a virus-related cancer epidemic Dahkki Shanthi Marur, Gypsyamber D’Souza, William H. Westra, Arlene A. Forastiere
Almmustuhtton 2010Revisão -
5
-
6
-
7
Phase III Study of Radiation Therapy With or Without Cis-Platinum in Patients With Unresectable Squamous or Undifferentiated Carcinoma of the Head and Neck: An Intergroup Trial of... Dahkki Harry Quon, Traci Leong, Robert E. Haselow, Bruce Leipzig, Jay S. Cooper, Arlene A. Forastiere
Almmustuhtton 2010Artigo -
8
A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck Dahkki Athanassios Argiris, Musie Ghebremichael, Barbara Burtness, Rita Axelrod, Ronald C. DeConti, Arlene A. Forastiere
Almmustuhtton 2011Artigo -
9
-
10
-
11
Prognostic significance of human papillomavirus in recurrent or metastatic head and neck cancer: an analysis of Eastern Cooperative Oncology Group trials Dahkki Athanassios Argiris, S. Li, Musie Ghebremichael, Ann Marie Egloff, Ling Wang, Arlene A. Forastiere, Barbara Burtness, Ranee Mehra
Almmustuhtton 2014Artigo -
12
Factors Associated With Severe Late Toxicity After Concurrent Chemoradiation for Locally Advanced Head and Neck Cancer: An RTOG Analysis Dahkki Mitchell Machtay, Jennifer Moughan, A. Trotti, Adam S. Garden, Randal S. Weber, Jay S. Cooper, Arlene A. Forastiere, K. Kian Ang
Almmustuhtton 2008Artigo -
13
Phase III Randomized, Placebo-Controlled Trial of Docetaxel With or Without Gefitinib in Recurrent or Metastatic Head and Neck Cancer: An Eastern Cooperative Oncology Group Trial Dahkki Athanassios Argiris, Musie Ghebremichael, Jill Gilbert, Ju-Whei Lee, Kamakshi Sachidanandam, Jill Kolesar, Barbara Burtness, Arlene A. Forastiere
Almmustuhtton 2013Artigo -
14
Dual EGFR and mTOR targeting in squamous cell carcinoma models, and development of early markers of efficacy Dahkki Antonio Jimeno, P. Kulesza, Jenna Wheelhouse, Andrew M. Chan, X Zhang, E Kincaid, Allen Chen, Douglas P. Clark, Arlene A. Forastiere, Manuel Hidalgo
Almmustuhtton 2007Artigo -
15
Endosonographic assessment of multimodality therapy predicts survival of esophageal carcinoma patients Dahkki Amitabh Chak, Marcia I. Canto, Gregory S. Cooper, Gerard Isenberg, Joseph Willis, Nathan Levitan, Julie Clayman, Arlene A. Forastiere, Elisabeth I. Heath, Michael Sivak
Almmustuhtton 2000Artigo -
16
Association between Cigarette Smoking and Mutation of the p53 Gene in Squamous-Cell Carcinoma of the Head and Neck Dahkki Joseph Brennan, Jay O. Boyle, Wayne M. Koch, Steven N. Goodman, Ralph H. Hruban, Yolanda Eby, Marion Couch, Arlene A. Forastiere, David Sidransky
Almmustuhtton 1995Artigo -
17
Long-Term Results of Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: A Phase II Trial of the Radiation Therapy Oncology Group (RTOG 99-... Dahkki Adam S. Garden, Jonathan Harris, Andy Trotti, Christopher U. Jones, Luis A. Carrascosa, Jonathan D. Cheng, Sharon Spencer, Arlene A. Forastiere, Randal S. Weber, K. Kian Ang
Almmustuhtton 2008Artigo -
18
Phase II Trial of Chemoradiation for Organ Preservation in Resectable Stage III or IV Squamous Cell Carcinomas of the Larynx or Oropharynx: Results of Eastern Cooperative Oncology... Dahkki Anthony J. Cmelak, Sigui Li, Meredith A. Goldwasser, Barbara A. Murphy, Michael W. Cannon, Harlan Pinto, David I. Rosenthal, Maura L. Gillison, Arlene A. Forastiere
Almmustuhtton 2007Artigo -
19
Hypopharyngeal Dose Is Associated With Severe Late Toxicity in Locally Advanced Head-and-Neck Cancer: An RTOG Analysis Dahkki Mitchell Machtay, Jennifer Moughan, Andrew Farach, Elizabeth Martin-O'Meara, James M. Galvin, Adam S. Garden, Randal S. Weber, Jay S. Cooper, Arlene A. Forastiere, K. Kian Ang
Almmustuhtton 2012Artigo -
20
Concomitant Boost Radiation Plus Concurrent Cisplatin for Advanced Head and Neck Carcinomas: Radiation Therapy Oncology Group Phase II Trial 99-14 Dahkki K. Kian Ang, Jonathan Harris, Adam S. Garden, Andy Trotti, Christopher U. Jones, Luis A. Carrascosa, Jonathan D. Cheng, Sharon Spencer, Arlene A. Forastiere, Randal S. Weber
Almmustuhtton 2005Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Internal medicine
Medicine
Oncology
Cancer
Surgery
Head and neck cancer
Radiation therapy
Chemotherapy
Gastroenterology
Head and neck
Head and neck squamous-cell carcinoma
Biology
Cisplatin
Larynx
Pathology
Carcinoma
Chemoradiotherapy
Confidence interval
Clinical trial
Genetics
Hazard ratio
Induction chemotherapy
Adenocarcinoma
Breast cancer
Cancer research
Colorectal cancer
Concomitant
Disease
Epidermal growth factor receptor
Esophageal cancer